216 related articles for article (PubMed ID: 33783856)
1. Fibrinogen reconstitution after therapeutic apheresis: Comparison of double-filtration plasmapheresis, plasma exchange, and immunoadsorption.
Jouve T; Marlu R; Naciri Bennani H; Noble J; Chevallier E; Motte L; Imerzoukene F; Malvezzi P; Rostaing L
J Clin Apher; 2021 Aug; 36(4):574-583. PubMed ID: 33783856
[TBL] [Abstract][Full Text] [Related]
2. Prediction of immunoglobulin M reduction via therapeutic dose of simple plasma exchange and double filtration plasmapheresis using membrane separation in patients with hyperviscosity syndrome caused by Waldenstrom macroglobulinemia.
Miyamoto Y; Hamasaki Y; Matsumoto A; Doi K; Noiri E; Nangaku M
J Clin Apher; 2018 Oct; 33(5):611-615. PubMed ID: 30188580
[TBL] [Abstract][Full Text] [Related]
3. Tryptophan-immobilized column-based immunoadsorption as the choice method for plasmapheresis in Guillain-Barré syndrome.
Okamiya S; Ogino M; Ogino Y; Irie S; Kanazawa N; Saito T; Sakai F
Ther Apher Dial; 2004 Jun; 8(3):248-53. PubMed ID: 15154879
[TBL] [Abstract][Full Text] [Related]
4. Isoagglutinin removal by plasma centrifugation or filtration (single or double): A prospective study in a single center.
Naciri Bennani H; Noble J; Chevallier E; Terrec F; Motte L; Giroux-Lathuile C; Bugnazet M; Imerzoukene F; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Apher; 2021 Feb; 36(1):149-160. PubMed ID: 33230824
[TBL] [Abstract][Full Text] [Related]
5. The impact of therapeutic plasma exchange and double filtration plasmapheresis on hemostasis in renal transplant recipients.
Vatazin AV; Zulkarnaev AB
Ter Arkh; 2018 Jun; 90(6):22-27. PubMed ID: 30701900
[TBL] [Abstract][Full Text] [Related]
6. Ability to remove immunoglobulins and anti-ganglioside antibodies by plasma exchange, double-filtration plasmapheresis and immunoadsorption.
Tagawa Y; Yuki N; Hirata K
J Neurol Sci; 1998 Apr; 157(1):90-5. PubMed ID: 9600682
[TBL] [Abstract][Full Text] [Related]
7. Indications, technique, and outcome of therapeutic apheresis in European pediatric nephrology units.
Paglialonga F; Schmitt CP; Shroff R; Vondrak K; Aufricht C; Watson AR; Ariceta G; Fischbach M; Klaus G; Holtta T; Bakkaloglu SA; Zurowska A; Jankauskiene A; Vande Walle J; Schaefer B; Wright E; Connell R; Edefonti A
Pediatr Nephrol; 2015 Jan; 30(1):103-11. PubMed ID: 25135618
[TBL] [Abstract][Full Text] [Related]
8. Comparison of double filtration plasmapheresis with immunoadsorption therapy in patients with anti-glomerular basement membrane nephritis.
Zhang YY; Tang Z; Chen DM; Gong DH; Ji DX; Liu ZH
BMC Nephrol; 2014 Aug; 15():128. PubMed ID: 25086644
[TBL] [Abstract][Full Text] [Related]
9. Adjustment by hematocrit level in calculation of removal rate in therapeutic apheresis.
Sakurasawa T; Ohkubo A; Hoshikawa Y; Yamauchi D; Yamamoto H; Seshima H; Kurashima N; Iimori S; Rai T; Uchida S; Naito S
Ther Apher Dial; 2021 Aug; 25(4):425-431. PubMed ID: 33887113
[TBL] [Abstract][Full Text] [Related]
10. Removal Characteristics of Immunoadsorption with the Tryptophan-Immobilized Column Using Conventional and Selective Plasma Separators in the Treatment of Myasthenia Gravis.
Ohkubo A; Okado T; Sakurasawa T; Maeda T; Itagaki A; Yamamoto H; Miyamoto S; Seshima H; Kurashima N; Mori T; Iimori S; Sohara E; Rai T; Uchida S; Naito S
Ther Apher Dial; 2019 Jun; 23(3):271-278. PubMed ID: 31025833
[TBL] [Abstract][Full Text] [Related]
11. Double filtration plasmapheresis - 10-year pediatric experience as an alternative to plasma exchange.
Maxted AP; Connell R; Hussain F
Transfus Apher Sci; 2020 Dec; 59(6):102928. PubMed ID: 32919882
[TBL] [Abstract][Full Text] [Related]
12. Apheresis Efficacy and Tolerance in the Setting of HLA-Incompatible Kidney Transplantation.
Noble J; Metzger A; Naciri Bennani H; Daligault M; Masson D; Terrec F; Imerzoukene F; Bardy B; Fiard G; Marlu R; Chevallier E; Janbon B; Malvezzi P; Rostaing L; Jouve T
J Clin Med; 2021 Mar; 10(6):. PubMed ID: 33806743
[TBL] [Abstract][Full Text] [Related]
13. A prospective study comparing tryptophan immunoadsorption with therapeutic plasma exchange for the treatment of chronic inflammatory demyelinating polyneuropathy.
Lieker I; Slowinski T; Harms L; Hahn K; Klehmet J
J Clin Apher; 2017 Dec; 32(6):486-493. PubMed ID: 28485075
[TBL] [Abstract][Full Text] [Related]
14. The selective therapeutic apheresis procedures.
Sanchez AP; Cunard R; Ward DM
J Clin Apher; 2013 Feb; 28(1):20-9. PubMed ID: 23420592
[TBL] [Abstract][Full Text] [Related]
15. Effect of double-filtration plasmapheresis for antibody-mediated rejection on hemostasis parameters and thrombin generation.
Marlu R; Malvezzi P; Seyve L; Jouve T; Maurizi J; Defendi F; Carron PL; Christophe M; Le Gouellec A; Polack B; Rostaing L
Thromb Res; 2018 Jun; 166():113-121. PubMed ID: 29747114
[TBL] [Abstract][Full Text] [Related]
16. Advances in apheresis therapy for glomerular diseases.
Yokoyama H; Wada T; Zhang W; Yamaya H; Asaka M
Clin Exp Nephrol; 2007 Jun; 11(2):122-127. PubMed ID: 17593511
[TBL] [Abstract][Full Text] [Related]
17. Comparison between double-filtration plasmapheresis and immunoadsorption plasmapheresis in the treatment of patients with myasthenia gravis.
Yeh JH; Chiu HC
J Neurol; 2000 Jul; 247(7):510-3. PubMed ID: 10993491
[TBL] [Abstract][Full Text] [Related]
18. Efficacy of plasmapheresis and semi-selective immunoadsorption for removal of anti-HLA antibodies.
Jambon F; Merville P; Guidicelli G; Taton B; De Précigout V; Couzi L; Moreau K; Visentin J
J Clin Apher; 2021 Jun; 36(3):291-298. PubMed ID: 33253430
[TBL] [Abstract][Full Text] [Related]
19. The fluctuation of skin perfusion pressure in hemodialysis patients treated with LDL apheresis therapy: A comparison of LDL adsorption and double filtration plasmapheresis.
Yoshimura H; Yoshikawa Y; Noguchi Y; Totani T; Kusuta R; Shimazu K; Tanaka A; Komura K
J Clin Apher; 2023 Aug; 38(4):362-367. PubMed ID: 36367055
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of long-term lipid apheresis at a single center.
Koziolek MJ; Hennig U; Zapf A; Bramlage C; Grupp C; Armstrong VW; Strutz F; Müller GA
Ther Apher Dial; 2010 Apr; 14(2):143-52. PubMed ID: 20438535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]